3 Reasons to Sell GDRX and 1 Stock to Buy Instead [Yahoo! Finance]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Yahoo! Finance
This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation. Is there a buying opportunity in GoodRx, or does it present a risk to your portfolio? Dive into our full research report to see our analyst team's opinion, it's free Even though the stock has become cheaper, we're cautious about GoodRx. Here are three reasons why we avoid GDRX and a stock we'd rather own. Started in 2011 to tackle the problem of high prescription drug costs in America, GoodRx (NASDAQ:GDRX) operates a digital platform that helps consumers find lower prices on prescription medications through price comparison tools and discount codes. We at StockStory place the most emphasis on long-term growth, but within healthcare, a stretched historical view may miss recent innovations or disruptive industry trends. GoodRx's recent performance shows its demand has slowed as its annualized revenue growth of 1.7% over the last two years was below its five-year
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- GoodRx (NASDAQ:GDRX) had its "sell (d)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- When Should You Buy GoodRx Holdings, Inc. (NASDAQ:GDRX)? [Yahoo! Finance]Yahoo! Finance
- GoodRx (NASDAQ:GDRX) had its "sell (d)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- GoodRx (NASDAQ:GDRX) was given a new $4.00 price target on by analysts at Morgan Stanley.MarketBeat
- GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire
GDRX
Earnings
- 11/4/25 - Beat
GDRX
Sec Filings
- 12/22/25 - Form 4
- 12/12/25 - Form 8-K
- 12/8/25 - Form 4
- GDRX's page on the SEC website